1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sexually Transmitted Diseases Drug Consumption 2015-2025

2.1.2 Sexually Transmitted Diseases Drug Consumption CAGR by Region

2.2 Sexually Transmitted Diseases Drug Segment by Type

2.2.1 Antiviral / Antiretrovirals

2.2.2 Antibiotics

2.2.3 Vaccines

2.3 Sexually Transmitted Diseases Drug Consumption by Type

2.3.1 Global Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

2.3.2 Global Sexually Transmitted Diseases Drug Revenue and Market Share by Type (2015-2020)

2.3.3 Global Sexually Transmitted Diseases Drug Sale Price by Type (2015-2020)

2.4 Sexually Transmitted Diseases Drug Segment by Application

2.4.1 Hospital

2.4.2 Cinic

2.4.3 Other

2.5 Sexually Transmitted Diseases Drug Consumption by Application

2.5.1 Global Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

2.5.2 Global Sexually Transmitted Diseases Drug Value and Market Share by Type (2015-2020)

2.5.3 Global Sexually Transmitted Diseases Drug Sale Price by Type (2015-2020)

3 Global Sexually Transmitted Diseases Drug by Company

3.1 Global Sexually Transmitted Diseases Drug Sales Market Share by Company

3.1.1 Global Sexually Transmitted Diseases Drug Sales by Company (2018-2020)

3.1.2 Global Sexually Transmitted Diseases Drug Sales Market Share by Company (2018-2020)

3.2 Global Sexually Transmitted Diseases Drug Revenue Market Share by Company

3.2.1 Global Sexually Transmitted Diseases Drug Revenue by Company (2018-2020)

3.2.2 Global Sexually Transmitted Diseases Drug Revenue Market Share by Company (2018-2020)

3.3 Global Sexually Transmitted Diseases Drug Sale Price by Company

3.4 Global Sexually Transmitted Diseases Drug Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Sexually Transmitted Diseases Drug Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Sexually Transmitted Diseases Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Sexually Transmitted Diseases Drug by Regions

4.1 Sexually Transmitted Diseases Drug by Regions

4.2 Americas Sexually Transmitted Diseases Drug Consumption Growth

4.3 APAC Sexually Transmitted Diseases Drug Consumption Growth

4.4 Europe Sexually Transmitted Diseases Drug Consumption Growth

4.5 Middle East & Africa Sexually Transmitted Diseases Drug Consumption Growth

5 Americas

5.1 Americas Sexually Transmitted Diseases Drug Consumption by Countries

5.1.1 Americas Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020)

5.1.2 Americas Sexually Transmitted Diseases Drug Value by Countries (2015-2020)

5.2 Americas Sexually Transmitted Diseases Drug Consumption by Type

5.3 Americas Sexually Transmitted Diseases Drug Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Sexually Transmitted Diseases Drug Consumption by Regions

6.1.1 APAC Sexually Transmitted Diseases Drug Consumption by Regions (2015-2020)

6.1.2 APAC Sexually Transmitted Diseases Drug Value by Regions (2015-2020)

6.2 APAC Sexually Transmitted Diseases Drug Consumption by Type

6.3 APAC Sexually Transmitted Diseases Drug Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Sexually Transmitted Diseases Drug by Countries

7.1.1 Europe Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020)

7.1.2 Europe Sexually Transmitted Diseases Drug Value by Countries (2015-2020)

7.2 Europe Sexually Transmitted Diseases Drug Consumption by Type

7.3 Europe Sexually Transmitted Diseases Drug Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Sexually Transmitted Diseases Drug by Countries

8.1.1 Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Sexually Transmitted Diseases Drug Value by Countries (2015-2020)

8.2 Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Type

8.3 Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Sexually Transmitted Diseases Drug Distributors

10.3 Sexually Transmitted Diseases Drug Customer

11 Global Sexually Transmitted Diseases Drug Market Forecast

11.1 Global Sexually Transmitted Diseases Drug Consumption Forecast (2021-2025)

11.2 Global Sexually Transmitted Diseases Drug Forecast by Regions

11.2.1 Global Sexually Transmitted Diseases Drug Forecast by Regions (2021-2025)

11.2.2 Global Sexually Transmitted Diseases Drug Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast byRegions

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Sexually Transmitted Diseases Drug Forecast by Type

11.8 Global Sexually Transmitted Diseases Drug Forecast by Application

12 Key Players Analysis

12.1 Pfizer INC

12.1.1 Company Information

12.1.2 Sexually Transmitted Diseases Drug Product Offered

12.1.3 Pfizer INC Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Pfizer INC Latest Developments

12.2 Merck & Co.

12.2.1 Company Information

12.2.2 Sexually Transmitted Diseases Drug Product Offered

12.2.3 Merck & Co. Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Merck & Co. Latest Developments

12.3 Hoffmann La Roche

12.3.1 Company Information

12.3.2 Sexually Transmitted Diseases Drug Product Offered

12.3.3 Hoffmann La Roche Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Hoffmann La Roche Latest Developments

12.4 Bayer Healthcare

12.4.1 Company Information

12.4.2 Sexually Transmitted Diseases Drug Product Offered

12.4.3 Bayer Healthcare Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Bayer Healthcare Latest Developments

12.5 Gilead Sciences

12.5.1 Company Information

12.5.2 Sexually Transmitted Diseases Drug Product Offered

12.5.3 Gilead Sciences Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Gilead Sciences Latest Developments

12.6 Johnson & Johnson

12.6.1 Company Information

12.6.2 Sexually Transmitted Diseases Drug Product Offered

12.6.3 Johnson & Johnson Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Johnson & Johnson Latest Developments

12.7 Eli Lilly

12.7.1 Company Information

12.7.2 Sexually Transmitted Diseases Drug Product Offered

12.7.3 Eli Lilly Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Eli Lilly Latest Developments

12.8 GlaxoSmithKline Plc

12.8.1 Company Information

12.8.2 Sexually Transmitted Diseases Drug Product Offered

12.8.3 GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 GlaxoSmithKline Plc Latest Developments

12.9 Bristol-Myers Squibb Co. AbbVie

12.9.1 Company Information

12.9.2 Sexually Transmitted Diseases Drug Product Offered

12.9.3 Bristol-Myers Squibb Co. AbbVie Sexually Transmitted Diseases Drug Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Bristol-Myers Squibb Co. AbbVie Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Sexually Transmitted Diseases Drug Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Antiviral / Antiretrovirals

Table 5. Major Players of Antibiotics

Table 6. Major Players of Vaccines

Table 7. Global Consumption Sales by Type (2015-2020)

Table 8. Global Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Table 9. Global Sexually Transmitted Diseases Drug Revenue by Type (2015-2020) ($ million)

Table 10. Global Sexually Transmitted Diseases Drug Value Market Share by Type (2015-2020) ($ Millions)

Table 11. Global Sexually Transmitted Diseases Drug Sale Price by Type (2015-2020)

Table 12. Global Consumption Sales by Application (2015-2020)

Table 13. Global Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Table 14. Global Sexually Transmitted Diseases Drug Value by Application (2015-2020)

Table 15. Global Sexually Transmitted Diseases Drug Value Market Share by Application (2015-2020)

Table 16. Global Sexually Transmitted Diseases Drug Sale Price by Application (2015-2020)

Table 17. Global Sexually Transmitted Diseases Drug Sales by Company (2017-2019) (MT)

Table 18. Global Sexually Transmitted Diseases Drug Sales Market Share by Company (2017-2019)

Table 19. Global Sexually Transmitted Diseases Drug Revenue by Company (2017-2019) ($ Millions)

Table 20. Global Sexually Transmitted Diseases Drug Revenue Market Share by Company (2017-2019)

Table 21. Global Sexually Transmitted Diseases Drug Sale Price by Company (2017-2019)

Table 22. Global Sexually Transmitted Diseases Drug Manufacturing Base Distribution and Sales Area by Manufacturers

Table 23. Players Sexually Transmitted Diseases Drug Products Offered

Table 24. Sexually Transmitted Diseases Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 25. Global Sexually Transmitted Diseases Drug Consumption by Regions 2015-2020 (MT)

Table 26. Global Sexually Transmitted Diseases Drug Consumption Market Share by Regions 2015-2020

Table 27. Global Sexually Transmitted Diseases Drug Value by Regions 2015-2020 ($ Millions)

Table 28. Global Sexually Transmitted Diseases Drug Value Market Share by Regions 2015-2020

Table 29. Americas Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020) (MT)

Table 30. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Countries (2015-2020)

Table 31. Americas Sexually Transmitted Diseases Drug Value by Countries (2015-2020) ($ Millions)

Table 32. Americas Sexually Transmitted Diseases Drug Value Market Share by Countries (2015-2020)

Table 33. Americas Sexually Transmitted Diseases Drug Consumption by Type (2015-2020) (MT)

Table 34. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Table 35. Americas Sexually Transmitted Diseases Drug Consumption by Application (2015-2020) (MT)

Table 36. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Table 37. APAC Sexually Transmitted Diseases Drug Consumption by Regions (2015-2020) (MT)

Table 38. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Regions (2015-2020)

Table 39. APAC Sexually Transmitted Diseases Drug Value by Regions (2015-2020) ($ Millions)

Table 40. APAC Sexually Transmitted Diseases Drug Value Market Share by Regions (2015-2020)

Table 41. APAC Sexually Transmitted Diseases Drug Consumption by Type (2015-2020) (MT)

Table 42. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Table 43. APAC Sexually Transmitted Diseases Drug Consumption by Application (2015-2020) (MT)

Table 44. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Table 45. Europe Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020) (MT)

Table 46. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Countries (2015-2020)

Table 47. Europe Sexually Transmitted Diseases Drug Value by Countries (2015-2020) ($ Millions)

Table 48. Europe Sexually Transmitted Diseases Drug Value Market Share by Countries (2015-2020)

Table 49. Europe Sexually Transmitted Diseases Drug Consumption by Type (2015-2020) (MT)

Table 50. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Table 51. Europe Sexually Transmitted Diseases Drug Consumption by Application (2015-2020) (MT)

Table 52. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Table 53. Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Countries (2015-2020) (MT)

Table 54. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Countries (2015-2020)

Table 55. Middle East & Africa Sexually Transmitted Diseases Drug Value by Countries (2015-2020) ($ Millions)

Table 56. Middle East & Africa Sexually Transmitted Diseases Drug Value Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Type (2015-2020) (MT)

Table 58. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Table 59. Middle East & Africa Sexually Transmitted Diseases Drug Consumption by Application (2015-2020) (MT)

Table 60. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Table 61. Sexually Transmitted Diseases Drug Distributors List

Table 62. Sexually Transmitted Diseases Drug Customer List

Table 63. Global Sexually Transmitted Diseases Drug Consumption Forecast by Countries (2021-2025) (MT)

Table 64. Global Sexually Transmitted Diseases Drug Consumption Market Forecast by Regions

Table 65. Global Sexually Transmitted Diseases Drug Value Forecast by Countries (2021-2025) ($ Millions)

Table 66. Global Sexually Transmitted Diseases Drug Value Market Share Forecast by Regions

Table 67. Global Sexually Transmitted Diseases Drug Consumption Forecast by Type (2021-2025) (MT)

Table 68. Global Sexually Transmitted Diseases Drug Consumption Market Share Forecast by Type (2021-2025)

Table 69. Global Sexually Transmitted Diseases Drug Value Forecast by Type (2021-2025) ($ Millions)

Table 70. Global Sexually Transmitted Diseases Drug Value Market Share Forecast by Type (2021-2025)

Table 71. Global Sexually Transmitted Diseases Drug Consumption Forecast by Application (2021-2025) (MT)

Table 72. Global Sexually Transmitted Diseases Drug Consumption Market Share Forecast by Application (2021-2025)

Table 73. Global Sexually Transmitted Diseases Drug Value Forecast by Application (2021-2025) ($ Millions)

Table 74. Global Sexually Transmitted Diseases Drug Value Market Share Forecast by Application (2021-2025)

Table 75. Pfizer INC Product Offered

Table 76. Pfizer INC Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 77. Pfizer INC Main Business

Table 78. Pfizer INC Latest Developments

Table 79. Pfizer INC Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 80. Merck & Co. Product Offered

Table 81. Merck & Co. Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 82. Merck & Co. Main Business

Table 83. Merck & Co. Latest Developments

Table 84. Merck & Co. Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 85. Hoffmann La Roche Product Offered

Table 86. Hoffmann La Roche Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 87. Hoffmann La Roche Main Business

Table 88. Hoffmann La Roche Latest Developments

Table 89. Hoffmann La Roche Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 90. Bayer Healthcare Product Offered

Table 91. Bayer Healthcare Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 92. Bayer Healthcare Main Business

Table 93. Bayer Healthcare Latest Developments

Table 94. Bayer Healthcare Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Gilead Sciences Product Offered

Table 96. Gilead Sciences Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 97. Gilead Sciences Main Business

Table 98. Gilead Sciences Latest Developments

Table 99. Gilead Sciences Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Johnson & Johnson Product Offered

Table 101. Johnson & Johnson Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 102. Johnson & Johnson Main Business

Table 103. Johnson & Johnson Latest Developments

Table 104. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Eli Lilly Product Offered

Table 106. Eli Lilly Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 107. Eli Lilly Main Business

Table 108. Eli Lilly Latest Developments

Table 109. Eli Lilly Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 110. GlaxoSmithKline Plc Product Offered

Table 111. GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 112. GlaxoSmithKline Plc Main Business

Table 113. GlaxoSmithKline Plc Latest Developments

Table 114. GlaxoSmithKline Plc Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Bristol-Myers Squibb Co. AbbVie Product Offered

Table 116. Bristol-Myers Squibb Co. AbbVie Sexually Transmitted Diseases Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 117. Bristol-Myers Squibb Co. AbbVie Main Business

Table 118. Bristol-Myers Squibb Co. AbbVie Latest Developments

Table 119. Bristol-Myers Squibb Co. AbbVie Basic Information, Company Total Revenue (in $ million), Sexually Transmitted Diseases Drug Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Sexually Transmitted Diseases Drug

Figure 2. Sexually Transmitted Diseases Drug Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Sexually Transmitted Diseases Drug Consumption Growth Rate 2015-2025 (MT)

Figure 5. Global Sexually Transmitted Diseases Drug Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Antiviral / Antiretrovirals

Figure 7. Product Picture of Antibiotics

Figure 8. Product Picture of Vaccines

Figure 9. Global Sexually Transmitted Diseases Drug Consumption Market Share by Type (2015-2020)

Figure 10. Global Sexually Transmitted Diseases Drug Value Market Share by Type (2015-2020)

Figure 11. Sexually Transmitted Diseases Drug Consumed in Hospital

Figure 12. Global Sexually Transmitted Diseases Drug Market: Hospital (2015-2020) (MT)

Figure 13. Global Sexually Transmitted Diseases Drug Market: Hospital (2015-2020) ($ Millions)

Figure 14. Sexually Transmitted Diseases Drug Consumed in Cinic

Figure 15. Global Sexually Transmitted Diseases Drug Market: Cinic (2015-2020) (MT)

Figure 16. Global Sexually Transmitted Diseases Drug Market: Cinic (2015-2020) ($ Millions)

Figure 17. Sexually Transmitted Diseases Drug Consumed in Other

Figure 18. Global Sexually Transmitted Diseases Drug Market: Other (2015-2020) (MT)

Figure 19. Global Sexually Transmitted Diseases Drug Market: Other (2015-2020) ($ Millions)

Figure 20. Global Sexually Transmitted Diseases Drug Consumption Market Share by Application (2015-2020)

Figure 21. Global Sexually Transmitted Diseases Drug Value Market Share by Application (2015-2020)

Figure 22. Global Sexually Transmitted Diseases Drug Sales Market Share by Company in 2017

Figure 23. Global Sexually Transmitted Diseases Drug Sales Market Share by Company in 2019

Figure 24. Global Sexually Transmitted Diseases Drug Revenue Market Share by Company in 2017

Figure 25. Global Sexually Transmitted Diseases Drug Revenue Market Share by Company in 2019

Figure 26. Global Sexually Transmitted Diseases Drug Sale Price by Company in 2019

Figure 27. Global Sexually Transmitted Diseases Drug Consumption Market Share by Regions 2015-2020

Figure 28. Global Sexually Transmitted Diseases Drug Value Market Share by Regions 2015-2020

Figure 29. Americas Sexually Transmitted Diseases Drug Consumption 2015-2020 (MT)

Figure 30. Americas Sexually Transmitted Diseases Drug Value 2015-2020 ($ Millions)

Figure 31. APAC Sexually Transmitted Diseases Drug Consumption 2015-2020 (MT)

Figure 32. APAC Sexually Transmitted Diseases Drug Value 2015-2020 ($ Millions)

Figure 33. Europe Sexually Transmitted Diseases Drug Consumption 2015-2020 (MT)

Figure 34. Europe Sexually Transmitted Diseases Drug Value 2015-2020 ($ Millions)

Figure 35. Middle East & Africa Sexually Transmitted Diseases Drug Consumption 2015-2020 (MT)

Figure 36. Middle East & Africa Sexually Transmitted Diseases Drug Value 2015-2020 ($ Millions)

Figure 37. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Countries in 2019

Figure 38. Americas Sexually Transmitted Diseases Drug Value Market Share by Countries in 2019

Figure 39. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Type in 2019

Figure 40. Americas Sexually Transmitted Diseases Drug Consumption Market Share by Application in 2019

Figure 41. United States Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 42. United States Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 43. Canada Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 44. Canada Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 45. Mexico Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 46. Mexico Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 47. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Countries in 2019

Figure 48. APAC Sexually Transmitted Diseases Drug Value Market Share by Regions in 2019

Figure 49. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Type in 2019

Figure 50. APAC Sexually Transmitted Diseases Drug Consumption Market Share by Application in 2019

Figure 51. China Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 52. China Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 53. Japan Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 54. Japan Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 55. Korea Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 56. Korea Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 57. Southeast Asia Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 58. Southeast Asia Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 59. India Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 60. India Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 61. Australia Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 62. Australia Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 63. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Countries in 2019

Figure 64. Europe Sexually Transmitted Diseases Drug Value Market Share by Countries in 2019

Figure 65. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Type in 2019

Figure 66. Europe Sexually Transmitted Diseases Drug Consumption Market Share by Application in 2019

Figure 67. Germany Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 68. Germany Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 69. France Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 70. France Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 71. UK Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 72. UK Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 73. Italy Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 74. Italy Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 75. Russia Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 76. Russia Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 77. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Countries in 2019

Figure 78. Middle East & Africa Sexually Transmitted Diseases Drug Value Market Share by Countries in 2019

Figure 79. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Type in 2019

Figure 80. Middle East & Africa Sexually Transmitted Diseases Drug Consumption Market Share by Application in 2019

Figure 81. Egypt Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 82. Egypt Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 83. South Africa Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 84. South Africa Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 85. Israel Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 86. Israel Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 87. Turkey Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 88. Turkey Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 89. GCC Countries Sexually Transmitted Diseases Drug Consumption Growth 2015-2020 (MT)

Figure 90. GCC Countries Sexually Transmitted Diseases Drug Value Growth 2015-2020 ($ Millions)

Figure 91. Global Sexually Transmitted Diseases Drug Consumption Growth Rate Forecast (2021-2025) (MT)

Figure 92. Global Sexually Transmitted Diseases Drug Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 93. Americas Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 94. Americas Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 95. APAC Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 96. APAC Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 97. Europe Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 98. Europe Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 99. Middle East & Africa Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 100. Middle East & Africa Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 101. United States Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 102. United States Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 103. Canada Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 104. Canada Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 105. Mexico Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 106. Mexico Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 107. Brazil Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 108. Brazil Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 109. China Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 110. China Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 111. Japan Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 112. Japan Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 113. Korea Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 114. Korea Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 115. Southeast Asia Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 116. Southeast Asia Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 117. India Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 118. India Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 119. Australia Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 120. Australia Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 121. Germany Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 122. Germany Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 123. France Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 124. France Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 125. UK Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 126. UK Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 127. Italy Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 128. Italy Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 129. Russia Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 130. Russia Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 131. Spain Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 132. Spain Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 133. Egypt Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 134. Egypt Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 135. South Africa Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 136. South Africa Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 137. Israel Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 138. Israel Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 139. Turkey Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 140. Turkey Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 141. GCC Countries Sexually Transmitted Diseases Drug Consumption 2021-2025 (MT)

Figure 142. GCC Countries Sexually Transmitted Diseases Drug Value 2021-2025 ($ Millions)

Figure 143. Pfizer INC Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 144. Merck & Co. Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 145. Hoffmann La Roche Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 146. Bayer Healthcare Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 147. Gilead Sciences Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 148. Johnson & Johnson Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 149. Eli Lilly Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 150. GlaxoSmithKline Plc Sexually Transmitted Diseases Drug Market Share (2018-2020)

Figure 151. Bristol-Myers Squibb Co. AbbVie Sexually Transmitted Diseases Drug Market Share (2018-2020)